These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37043373)

  • 1. Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.
    Bolier M; van der Lelij AJ; Janssens GO; van den Heuvel-Eibrink MM; Neggers SJCMM
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
    Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis.
    Tamhane S; Sfeir JG; Kittah NEN; Jasim S; Chemaitilly W; Cohen LE; Murad MH
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2794-2801. PubMed ID: 29982555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation.
    Rose SR; Carlsson M; Grimberg A; Aydin F; Albanese A; Hokken-Koelega ACS; Camacho-Hubner C
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3730-41. PubMed ID: 32706856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?
    van Bunderen CC; Olsson DS
    Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101835. PubMed ID: 37914564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
    Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
    Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
    Beckers D; Thomas M; Jamart J; Francois I; Maes M; Lebrethon MC; De Waele K; Tenoutasse S; De Schepper J
    Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment and quality of life among survivors of childhood cancer.
    Eiser C; Vance YH; Glaser A; Galvin H; Horne B; Picton S; Stoner A; Butler G
    Horm Res; 2005; 63(6):300-4. PubMed ID: 16020938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH deficiency in adult survivors of childhood cancer.
    Felicetti F; Fortunati N; Arvat E; Brignardello E
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):795-804. PubMed ID: 27974192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
    Johannsson G; Ragnarsson O
    J Intern Med; 2021 Dec; 290(6):1180-1193. PubMed ID: 34605087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
    Boguszewski MCS; Boguszewski CL; Chemaitilly W; Cohen LE; Gebauer J; Higham C; Hoffman AR; Polak M; Yuen KCJ; Alos N; Antal Z; Bidlingmaier M; Biller BMK; Brabant G; Choong CSY; Cianfarani S; Clayton PE; Coutant R; Cardoso-Demartini AA; Fernandez A; Grimberg A; Guðmundsson K; Guevara-Aguirre J; Ho KKY; Horikawa R; Isidori AM; Jørgensen JOL; Kamenicky P; Karavitaki N; Kopchick JJ; Lodish M; Luo X; McCormack AI; Meacham L; Melmed S; Mostoufi Moab S; Müller HL; Neggers SJCMM; Aguiar Oliveira MH; Ozono K; Pennisi PA; Popovic V; Radovick S; Savendahl L; Touraine P; van Santen HM; Johannsson G
    Eur J Endocrinol; 2022 Apr; 186(6):P35-P52. PubMed ID: 35319491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
    Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.
    Boguszewski MCS; Cardoso-Demartini AA; Boguszewski CL; Chemaitilly W; Higham CE; Johannsson G; Yuen KCJ
    Pituitary; 2021 Oct; 24(5):810-827. PubMed ID: 34304361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.
    He X; Barkan AL
    Pituitary; 2020 Jun; 23(3):294-306. PubMed ID: 32060708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.
    Alter C; Boguszewski M; Clemmons D; Dobri GA; Geffner ME; Kelepouris N; Miller BS; Oh R; Shea H; Yuen KCJ
    Growth Horm IGF Res; 2024 Feb; 74():101573. PubMed ID: 38368660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
    Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
    Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
    Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing's disease.
    Boguszewski CL
    Pituitary; 2022 Oct; 25(5):760-763. PubMed ID: 35552989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.